Press release
06.01.2021 To the attention of interested persons EMA press release: Update on rolling review of AstraZeneca’s COVID-19 vaccine download document […]
Press release
05.01.2021 To the attention of interested persons EMA press release: EMA public stakeholder meeting on COVID-19 download document … download […]
Press release
16.11.2020 To the attention of interested persons Nitrosamines: EMA aligns recommendations for sartans with those for other medicinal products download […]
Press release
22.10.2020 To the attention of interested persons EU authorities are investigating the presence of a nitrosamine impurity, 1-Nitroso-4-methyl piperazine (MeNP), […]
Press release
20.10.2020 To the attention of interested persons EU regulators require testing for nitrosamine impurities in metformin-containing medicinal products download document […]
Important notification
04.09.2020 To the attention of Romanian manufacturers/authorised representatives/importers The use of the EUDAMED “actors” registration module and of the single […]
Important notification
20.08.2020 To the attention of marketing authorisation holders As part of the EU-wide measures following the outcome of the assessment […]
Press release
09.07.2020 To the attention of interested persons EMA press release on the finalization of the opinion on the presence of […]
Important notification
16.06.2020 To the attention of interested persons The NAMMD would like to inform you about the 7th Romanian Pharmacovigilance Workshop […]
Important notification
26.03.2020 To the attention of marketing authorisation holders Information on nitrosamine impurities for marketing authorisation holders download document …